JP2013147511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013147511A5 JP2013147511A5 JP2013097681A JP2013097681A JP2013147511A5 JP 2013147511 A5 JP2013147511 A5 JP 2013147511A5 JP 2013097681 A JP2013097681 A JP 2013097681A JP 2013097681 A JP2013097681 A JP 2013097681A JP 2013147511 A5 JP2013147511 A5 JP 2013147511A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- inflammation
- meta arsenite
- sodium meta
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89900707P | 2007-02-02 | 2007-02-02 | |
| US60/899,007 | 2007-02-02 | ||
| US12/068,006 US8945505B2 (en) | 2007-02-02 | 2008-01-31 | Use of arsenic compounds for treatment of pain and inflammation |
| US12/068,006 | 2008-01-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548463A Division JP5411709B2 (ja) | 2007-02-02 | 2008-02-01 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014209816A Division JP5853347B2 (ja) | 2007-02-02 | 2014-10-14 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013147511A JP2013147511A (ja) | 2013-08-01 |
| JP2013147511A5 true JP2013147511A5 (enExample) | 2013-12-12 |
| JP5825611B2 JP5825611B2 (ja) | 2015-12-02 |
Family
ID=39322911
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548463A Expired - Fee Related JP5411709B2 (ja) | 2007-02-02 | 2008-02-01 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
| JP2013097681A Expired - Fee Related JP5825611B2 (ja) | 2007-02-02 | 2013-05-07 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
| JP2014209816A Expired - Fee Related JP5853347B2 (ja) | 2007-02-02 | 2014-10-14 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548463A Expired - Fee Related JP5411709B2 (ja) | 2007-02-02 | 2008-02-01 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014209816A Expired - Fee Related JP5853347B2 (ja) | 2007-02-02 | 2014-10-14 | 痛みおよび炎症の処置のためのヒ素化合物の使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8945505B2 (enExample) |
| EP (1) | EP2114419B8 (enExample) |
| JP (3) | JP5411709B2 (enExample) |
| KR (1) | KR101479519B1 (enExample) |
| CN (2) | CN103550253A (enExample) |
| AR (1) | AR065138A1 (enExample) |
| AU (1) | AU2008214084C9 (enExample) |
| BR (1) | BRPI0807154B8 (enExample) |
| CA (3) | CA2677388C (enExample) |
| DK (1) | DK2114419T3 (enExample) |
| ES (1) | ES2460868T3 (enExample) |
| IL (3) | IL200173A (enExample) |
| MX (1) | MX2009008174A (enExample) |
| NZ (1) | NZ578621A (enExample) |
| PL (1) | PL2114419T3 (enExample) |
| RU (3) | RU2630574C2 (enExample) |
| TW (1) | TWI404538B (enExample) |
| WO (1) | WO2008097824A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090061022A1 (en) * | 2004-10-08 | 2009-03-05 | Sang Bong Lee | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8045505B2 (en) * | 2007-01-18 | 2011-10-25 | Science Applications International Corporation | Mechanism for automatic network formation and medium access coordination |
| JP5537441B2 (ja) | 2008-03-04 | 2014-07-02 | ファイザー・リミテッド | 慢性疼痛を治療する方法 |
| EP2432480B1 (en) * | 2009-05-18 | 2021-05-05 | The University of Hong Kong | Compositions and methods for treating inflammatory arthritis |
| KR101519192B1 (ko) | 2009-08-28 | 2015-05-11 | 리나트 뉴로사이언스 코프. | 칼시토닌 유전자-관련된 펩티드에 대해 지시된 길항제 항체의 투여에 의한 내장 통증의 치료 방법 |
| SI2475362T1 (sl) * | 2009-09-10 | 2019-08-30 | Kominox, Inc. | Terapija proti raku, ciljana na rakave matične celice in odporna proti zdravilom |
| FR3004949B1 (fr) * | 2013-04-26 | 2016-02-05 | Centre Nat Rech Scient | Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| HRP20240159T1 (hr) | 2014-03-21 | 2024-04-12 | Teva Pharmaceuticals International Gmbh | Antagonistička protutijela usmjerena protiv peptida povezanog s genom kalcitonina i postupci koji ih koriste |
| KR102015858B1 (ko) * | 2015-10-23 | 2019-08-30 | 손영태 | 법제된 비상을 함유하는 면역력 증강을 위한 약학적 조성물 |
| KR20220031944A (ko) | 2016-09-23 | 2022-03-14 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 불응성 편두통의 치료 |
| KR101834366B1 (ko) * | 2016-11-21 | 2018-03-05 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| KR101844049B1 (ko) * | 2016-12-05 | 2018-03-30 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물 |
| KR101844050B1 (ko) | 2016-12-09 | 2018-05-14 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물 |
| CN106890353A (zh) * | 2017-03-31 | 2017-06-27 | 应剑波 | 一种具有抗菌滋养功能的医用辅料 |
| US10716807B2 (en) * | 2017-05-09 | 2020-07-21 | Medsenic | Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide |
| JP7419333B2 (ja) * | 2018-03-22 | 2024-01-22 | コミファーム インターナショナル オーストラリア ピーティーワイ リミテッド | メタ亜ヒ酸塩を含む医薬組成物および製造方法 |
| RU2687599C1 (ru) * | 2018-11-22 | 2019-05-15 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Способ лечения постмастэктомического синдрома |
| CN109674817B (zh) * | 2019-01-31 | 2021-06-29 | 哈尔滨医科大学 | 三氧化二砷在制备治疗晚期动脉粥样硬化药物中的用途 |
| CA3138472C (en) * | 2019-05-21 | 2024-05-07 | Medsenic | Use of metal ions to potentiate the therapeutic effects of arsenic |
| JOP20220192A1 (ar) * | 2020-02-16 | 2023-01-30 | Panaphix Inc | طريقة علاج باستخدام ميتا-الزرنيخ |
| RU2755329C2 (ru) * | 2020-03-13 | 2021-09-15 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ ИМЕНИ АКАДЕМИКА А.М. ГРАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ /ФГБУ "РНЦРХТ им. академика А.М. Гранова" Минздрава России | Способ лечения нерезектабельной гилюсной холангиокарциномы |
| EP4527462A2 (en) * | 2020-04-03 | 2025-03-26 | Medsenic | Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune / inflammatory diseases in humans or animals |
| EP3988093A1 (en) * | 2020-10-22 | 2022-04-27 | Medsenic | Use of an arsenic compound for treating a cytokine storm |
| KR102240693B1 (ko) * | 2020-05-18 | 2021-04-15 | 주식회사 케마스 | 육산화사비소를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학조성물 |
| KR20220020633A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 주사제 조성물 |
| KR20220020637A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물 |
| WO2022133246A1 (en) | 2020-12-17 | 2022-06-23 | Vertex Pharmaceuticals Incorporated | Compositions and methods for editing beta-globin for treatment of hemaglobinopathies |
| WO2022159072A1 (en) | 2021-01-19 | 2022-07-28 | Micali Dr Silvio | Securing cryptographic keys |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US536273A (en) * | 1895-03-26 | Tavus rein | ||
| US1498639A (en) * | 1919-12-02 | 1924-06-24 | David S Pratt | Arsenical composition and method of making same |
| US3622664A (en) * | 1968-11-21 | 1971-11-23 | John A Brown | Treatment of infectious keratitis in animals with sodium arsenite |
| SU955909A1 (ru) * | 1980-06-25 | 1982-09-07 | Центральный Ордена Ленина Институт Усовершенствования Врачей | Способ профилактики осложнений при пересадке тканей |
| US4677974A (en) * | 1985-09-30 | 1987-07-07 | David Leonardi | Method and apparatus for immobilizing an eyelid |
| CA2051012C (en) | 1990-09-14 | 2002-04-02 | David R. Borcherding | Carbocyclic adenosine analogs useful as immunosupressants |
| ITTO930510A1 (it) | 1993-07-09 | 1993-10-07 | Walter Tarello | Farmaci attivi contro la chronic fatigue syndrome (c.f.s.) |
| US5889048A (en) | 1994-02-18 | 1999-03-30 | Vorobieva; Tamara Vasilievna | Methods and compositions for treating defective cell functions |
| US5362735A (en) * | 1994-02-23 | 1994-11-08 | Smithkline Beecham Corporation | Rapamycin derivatives |
| IT1272994B (it) * | 1994-05-25 | 1997-07-01 | Giampiero Valletta | Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.- |
| IT1295067B1 (it) * | 1997-09-25 | 1999-04-27 | Walter Tarello | Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale |
| DK1391206T3 (da) | 1997-10-15 | 2008-09-01 | Polarx Biopharmaceuticals Inc | Farmaceutiske præparater der omfatter arsentrioxyd til behandling af ikke-Hodgkins lymfom |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| TW200408407A (en) | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
| US6919343B2 (en) * | 2002-02-08 | 2005-07-19 | Merck & Co., Inc. | N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| PT1496918T (pt) | 2002-04-10 | 2023-05-25 | Komipharm Int Co Ltd | Utilização de meta-arsenito de sódio para o tratamento de tumores |
| RU2310460C2 (ru) * | 2002-04-10 | 2007-11-20 | Корея Микробиолоджикал Лабораторис, Лтд. | Фармацевтическая композиция для лечения злокачественной опухоли, содержащая арсенит натрия |
| FR2838965B1 (fr) | 2002-04-26 | 2004-06-25 | Centre Nat Rech Scient | Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme |
| JP2005206591A (ja) * | 2003-12-25 | 2005-08-04 | Mitsubishi Pharma Corp | 神経因性疼痛の予防及び／又は治療のための医薬 |
| WO2006069293A2 (en) * | 2004-12-22 | 2006-06-29 | Friedman Robert S | Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| JP2006206461A (ja) | 2005-01-26 | 2006-08-10 | Teizo Chinen | アレルギー疾患の予防・治療用組成物 |
| WO2006104292A1 (en) * | 2005-03-31 | 2006-10-05 | Komipharm International Co., Ltd. | Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US20060292243A1 (en) * | 2005-06-24 | 2006-12-28 | Shao-Chi Hsin | Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases |
-
2008
- 2008-01-31 US US12/068,006 patent/US8945505B2/en active Active
- 2008-02-01 MX MX2009008174A patent/MX2009008174A/es active IP Right Grant
- 2008-02-01 EP EP08714162.8A patent/EP2114419B8/en active Active
- 2008-02-01 CA CA2677388A patent/CA2677388C/en active Active
- 2008-02-01 DK DK08714162.8T patent/DK2114419T3/da active
- 2008-02-01 BR BRPI0807154A patent/BRPI0807154B8/pt not_active IP Right Cessation
- 2008-02-01 CA CA2845292A patent/CA2845292C/en active Active
- 2008-02-01 AR ARP080100429A patent/AR065138A1/es unknown
- 2008-02-01 AU AU2008214084A patent/AU2008214084C9/en not_active Ceased
- 2008-02-01 TW TW097104110A patent/TWI404538B/zh active
- 2008-02-01 RU RU2012134218A patent/RU2630574C2/ru active
- 2008-02-01 RU RU2009132951/15A patent/RU2468806C2/ru active
- 2008-02-01 CA CA2845299A patent/CA2845299C/en active Active
- 2008-02-01 PL PL08714162T patent/PL2114419T3/pl unknown
- 2008-02-01 KR KR1020097018389A patent/KR101479519B1/ko not_active Expired - Fee Related
- 2008-02-01 ES ES08714162.8T patent/ES2460868T3/es active Active
- 2008-02-01 WO PCT/US2008/052751 patent/WO2008097824A2/en not_active Ceased
- 2008-02-01 CN CN201310522816.6A patent/CN103550253A/zh active Pending
- 2008-02-01 JP JP2009548463A patent/JP5411709B2/ja not_active Expired - Fee Related
- 2008-02-01 NZ NZ578621A patent/NZ578621A/en not_active IP Right Cessation
- 2008-02-01 CN CN200880003873A patent/CN101641105A/zh active Pending
-
2009
- 2009-07-30 IL IL200173A patent/IL200173A/en active IP Right Grant
-
2012
- 2012-02-02 IL IL217891A patent/IL217891A/en not_active IP Right Cessation
-
2013
- 2013-04-24 US US13/869,911 patent/US10058570B2/en active Active
- 2013-05-07 JP JP2013097681A patent/JP5825611B2/ja not_active Expired - Fee Related
- 2013-11-05 IL IL229255A patent/IL229255A/en active IP Right Grant
- 2013-11-21 RU RU2013151904A patent/RU2665362C2/ru active
-
2014
- 2014-10-14 JP JP2014209816A patent/JP5853347B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013147511A5 (enExample) | ||
| Prantera et al. | Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease | |
| JP2018193377A5 (enExample) | ||
| Mevorach et al. | Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial | |
| JP2013505205A5 (enExample) | ||
| JP2011520911A5 (enExample) | ||
| JP2015505564A5 (enExample) | ||
| JP2013231087A5 (enExample) | ||
| JP2015038135A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2020522549A5 (enExample) | ||
| RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| JP2015508765A5 (enExample) | ||
| JP2013501049A5 (enExample) | ||
| MX2020010738A (es) | Formulaciones de ciclosporina para uso en el tratamiento del sindrome de bronquiolitis obliterante (bos). | |
| JP2016505050A5 (enExample) | ||
| MX391602B (es) | Composicion farmaceutica con antagonista del receptor de mineralocorticoides y su uso | |
| JP2016528171A5 (enExample) | ||
| JP2019535830A5 (enExample) | ||
| JP2010538054A5 (enExample) | ||
| Kim et al. | The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria | |
| IL292725A (en) | Benzazepines are combined for the treatment of Tourette syndrome | |
| Yu et al. | Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis | |
| Liu et al. | First case of low-dose umbilical cord blood therapy for pediatric acute respiratory distress syndrome induced by Pneumocystis carinii pneumonia |